Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets treat cat's eyelid condition with human lip filler
Nala's eye before (left) and after treatment.

Novel procedure avoids the need for general anaesthesia.

A kitten suffering from crippling eye pain and corneal damage has been treated using human lip filler.

Domestic shorthair Nala was born with a condition called eyelid coloboma, a common abnormality of cats in which parts of the upper eyelid do not form. In Nala's case, there was a small section missing in her upper right eyelid. 

Eyelid coloboma can result in corneal exposure and trichiasis (contact of facial hairs against the corneal surface). In turn, this can lead to chronic discomfort and severe damage to the cornea due to ulceration and scarring.

When Nala was presented to Davies Veterinary Specialists, she was in considerable discomfort with her right eye tightly closed. Ophthalmology clinician Rachel Lockhart explained that, given the amount of pain Nala was in, she would need some form of surgical correction.

Current surgical options for eyelid coloboma aim to reconstruct the upper eyelid by moving portions of the lower eyelid or even the upper lip into the defect. However, these surgeries can be extensive and often need multiple operations.

Before committing Nala and her owners to surgery, Rachel suggested an alternative option - sub-dermal sodium hyaluronate filler injections, most commonly known as human lip-filler.

The procedure involves injecting the filler under the skin surrounding the defect to realign the skin hairs and divert them away from the eye. While only a short-term fix, it can be performed under sedation, avoiding the need for general anaesthesia.

“The filler is broken down by the body and the effect is technically only temporary,” Rachel explained. “But it may persist for many months in some individuals so it can afford a good level of comfort for a considerable time. 

“Eventually Nala may need definitive surgery but for the time being the filler is keeping her eye comfortable.” 

Commenting on Nala's transformation, owner Lucy Peacock said: “Nala was clearly suffering and really struggled to keep her eye open - it was devastating to see her looking so dejected. We were really worried about the potential damage that was being caused to her sight in the long term, but after just a small and unobtrusive procedure, she is like a different kitten! 

“Rachel was so helpful in talking us through our potential options and making recommendations for what was best for Nala. We felt really at ease with the whole process, and whilst we are fully aware that Nala may need surgery in the future, we are just happy to see her back to her mischievous, adorable self for the time being. I can’t thank Rachel enough.”

Image (C) Davies Veterinary Specialists.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.